Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albo D, Wayne JD, Hunt KK, et. al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. American Journal of Surgery 2001;182(4):393–8
American Society of Breast Surgeons. Revised Consensus Statement on Guidelines for Performance of Sentinel Lymhpadenectomy for Breast Cancer [bulletin]. August 25, 2000
Barnwell JM, Arrendonodo, MA, Kollmorgen D, et al. Sentinel lymph node biopsy in breast cancer. Annals of Surgical Oncology 1998;5(2):126–130
Beahrs O, et al. Manual for Staging of Cancer. 4th ed. Philadelphia: Lippincott; 1992.
Bland KI. Enhancing the accuracy for predictors of axillary nodal metastasis in Tl carcinoma of the breast: Role of selective biopsy with lymphatic mapping. Journal of the American College of Surgeons 1996;183(3):262–4
Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidlines and pitfalls of lymphoscintigraphy and gamma probe detection. Journal of the American College of Surgeons 1998;186(3):275–283
Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet 1997;349(9066): 1668–9
Cabanes P, Salmon RJ, Vilcoq JR, et al. Value of axillary dissection in addition to lumpectomy and radio therapy in early brest cancer. Lancet 1992;329(8804):1245–1248
Cady B. Lymph node metastases. Indicators, but not governors of survival. Archives of Surgery 1984;119(9):1067–72
Carter C, Alan C, Henson DE. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 1989;63(1): 181–7
Cox CE, Salud CJ, Harrinton MA. The Role of Selective Sentinel Node Dissection in Breast Cancer. In: Leong SPL, Wong JH, editors. The Surgical Clinics of North America: Sentinel Lymph Nodes in Human Solid Cancer. Philadelphia: WB Saunders, 2000; 80(6): 1759–1777
Cox CE, Bass SS, Boulware D, et al. Implementation of New Surgical Technology: Outcome Measures for Lymphatic Mapping of Breast Carcinoma. Annals of Surgical Oncology 1999;6(6):553–561
Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Annals of Surgery 1998;227(5):645–51; discussion 651–3
Cancer Research Campaign Working Party. Cancer research campaign trial for early breast cancer. Lancet 1980;11:55–60
Fisher B, Redmond C, Poisson R, et al. Eight year results of a randomized clinical trial comparing total mastectomy and lumpectomy with and without irradiation in the treatment of breast cancer. New England Journal of Medicine 1989;320(13):822–828
Fisher B, Redmond C, Fisher ER, et al. Ten year results of randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. New England Journal of Medicine 1985;312(11):674–682
Fisher B, Wolmark N, Bauer M, et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histological nodal status in carcinoma of the breast. Surgery, Gynecology and Obstetrics 1981;152(6):765–72
Giuliano AE. See One, Do Twenty-Five, Teach One: the implementation of Sentinel Node Dissection in Breast Cancer. Annals of Surgical Oncology 1999a;6:520–521
Giuliano AE. Mapping a pathway for axillary staging: a personal perspective on the current status of sentinel lymph node dissection for breast cancer. Archives of Surgery 1999b;134(2):195–9
Giuliano AE. Intradermal Blue Dye to Identify Sentinel Lymph Node in Breast Cancer. Lancet 1997a;350(9082):958
Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. Journal of Clinical Oncology 1997b;15(6):2345–50
Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Annals of Surgery 1994;220(3):391–8; discussion 398–401
Grant RN, Tabah EJ, Adair FE. The surgical significance of the subareolar plexus in cancer of the breast. Surgery 1959;33:71–78
Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer Journal 1997;3(6):336–40
Haagensen CD, Feind CR, Herter FP, et al. The Lymphatics in Cancer. Philadelphia: WB Saunders; 1972.
Harlow SP, Krag DN, Weaver DL, et al. Extra-Axillary Sentinel Lymph Nodes in Breast Cancer. Breast Cancer 1999;6:159–165
Hayward J. The surgeon’s role in primary breast cancer. Breast Cancer Research and Treatment 1981;1:27–32
Ivens D, Hoe AL, Podd TJ, et al. Assessment of morbidity from complete axillary dissection. British Journal of Cancer 1992;66(1):136–138
Kern KA, Rosenberg RJ. Preoperative Lymphoscintigraphy During Lymphatic Mapping for Breast Cancer: Improved Sentinel Node Imaging Using Subareolar Injection of Technetium 99m Sulfur Colloid. Journal of the American College of Surgeons 2000;191:479–489
Klimberg VS, Rubio IT, Henry R, et al. Subareolar versus peritumoral injection for location of the sentinel lymph node. Annals of Surgery 1999;229(6):860–4; discussion 864–5
Kowalsky RJ, Perry JR. Radiopharmaceuticals in Nuclear Medicine Practice. Los Altos: Appleton and Lange, 1987. p.271–314.
Krag D. The Sentinel Node for Staging Breast Cancer: Current Review. Breast Cancer 1999;6:233–236
Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer—a multicenter validation study. New England Journal of Medicine 1998;339(14):941–6
Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surgical Oncology 1993;2(6):335–9; discussion 340
Langlands AO, Prescott RJ, Hamilton T. A clinical trial in the management of operable breast cancer. British Journal of Surgery 1980;67(3):170–174
Leong SPL, Morita ET, Treseler PA, et al. Multidisciplinary Approach to Selective Sentinel Lymph Node Mapping in Breast Cancer. Breast Cancer 2000a;7(2):105–113
Leong SPL, Donegan E, Heffernon W, et al. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Annals of Surgical Oncology 2000b;7:361–6
Leong SPL, Steinmetz I, Habib FA, et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Archives of Surgery 1997;132(6):666–73; discussion 673
Linehan DC, Hill AD, Tran KN, et al. Sentinel lymph node biopsy in breast cancer: unfiltered radioisotope is superior to filtered. Journal of the American College of Surgeons 1999;188(4):377–81
McArdle CS, Crawford D, Dykes EH, et al. Adjuvant radiotherapy and chemotherapy in breast cancer. British Journal of Surgery 1986;73(4):264–6
McMasters KM, Wong SL, Martin RC 2d, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Annals of Surgery 2001;233:676–687
Morton DL, Wen DR, Wong JH. Technical details of intraoperative lymphatic mapping for early stage melanoma. Archives of Surgery 1992;127(4):392–9
Neiweg OEK, Peterse JL, et al. Identification of sentinel node in patients with breast carcinoma. Ned Tijdschr Geneeskd 1996;140:2235–39
Nemoto T, Vana J, Bedwani RN, et al. Management and survival of female breast cancer: Results of a national survery by the American College of Surgeons. Cancer 1980;45(12):2917–24
NIHCC. NIoHCc: Treatment of early breast cancer. JAMA 1991;265:391–5
O’Hea BHA, Hill AD, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer [see comments]. Journal of the American College of Surgeons 1998;186(4):423–427
Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival — a Bayesian metaanalysis. Annals of Surgical Oncology 1999;6(1):109–116
Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. New England Journal of Medicine 1997;337(14):949–955
Pijpers R, Meijer S, Hoekstra OS, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. Journal of Nuclear Medicine 1997;38(3):366–8
Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. New England Journal of Medicine 1997;337(14):956–962
Roumen RM, Geuskens LM, Valkenburg JG. In search of the true sentinel node by different injection techniques in breast cancer patients. European Journal of Surgical Oncology 1999;25(4):347–51
Rouviere H. Anatomie des Lymphatiques de ľHomme. Paris: Masson, 1932.
Rutquist L, Petterson D, Johansson H. Adjuvant radiation therapy versus surgery alone in operable breast cancer; long-term follow-up in a randomized clinical trial. Radiotherapy and Oncology 1993;104:26
Sappey MPC. Anatomie, physiologie, pathologie des vaisseaux lymphatiques consideres chez I’homme et les vertebres. Paris, DeLahaye A, Lecrosnier, 1874.
Schneebaum SSY, Cohen M, et al. Sentinel lymph node localization in breast cancer — A feasibility study. Presented SSO meeting in Atlanta, GA, 1996.
Turner RR, Ollila DW, Krasne DL, et al. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Annals of Surgery 1997;226(3):271–6
Turner-Warwick RT. The lymphatics of the breast. British Journal of Surgery 1953;46:574–82
Vendrell-Tome E, Setoain-Quinquer, Domenech-Torne FM. Study of Normal Mammary Lymphatic Drainage Using Radiotracer Isotopes. Journal of Nuclear Medicine 1972;13(11):801–805
Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349(9069):1864–7
White R, Vezeridis MP, Konstadoulakis M, et al. Therapeutic options and results for the management of minimally invasive carcinoma of the breast; influence of axillary dissection for treatment of T1a and T1b lesions. Journal of the American College of Surgeons 1996;1836):575–522
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Leong, S.P.L. (2002). Selective Sentinel Lymph Node Mapping and Dissection for Breast Cancer. In: Leong, S.P.L. (eds) Atlas of Selective Sentinel Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer. Cancer Treatment and Research, vol 111. Springer, Boston, MA. https://doi.org/10.1007/0-306-47822-6_4
Download citation
DOI: https://doi.org/10.1007/0-306-47822-6_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4020-7013-6
Online ISBN: 978-0-306-47822-2
eBook Packages: Springer Book Archive